spacer
home > about us
Samedan Ltd. Pharmaceutical Publishers

Specialist pharmaceutical publisher Samedan Ltd is a dynamic, forward-thinking company, enjoying year-on-year growth with its five market-leading titles for industry professionals: European Pharmaceutical Contractor, Pharmaceutical Manufacturing and Packing Sourcer, European Biopharmaceutical Review, Innovations in Pharmaceutical Technology, and International Clinical Trials.

In 2013, the company extended its range with the acquisition of the Pharmafile portfolio, consisting of Pharmafocus newspaper, www.pharmafile.com, and Pharmafile directory. The London-based company has been producing a wide range of magazines for the
global pharmaceutical arena since 1996, covering a wide range of hot topics including R&D, clinical trials, cutting-edge technology, manufacture, packaging, logistics, regulations, and industry insight.

Located in an idyllic region synonymous with culture and quality, the Alpine village
of Samedan is renowned for its tradition of hospitality and shares many of its ideals
with the company it inspired. Samedan hopes to develop its ties with the industry
further still and maintains a fresh vision for the future. In 2006, Samedan took on
Air Transport Publications
, bringing the same ethos to a whole new sector.

spacer

Industry Events

FlyPharma Europe

22-23 October 2019, Copenhagen, Denmark

The FlyPharma Conference Europe 2019 is aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chain. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. There will be plenty of networking opportunities, including a complimentary evening networking event, where delegates can meet and catch up with senior and executive pharma and cargo professionals gaining strong, new industry contacts and building on existing ones.
More info >>

News and Press Releases

Regulatory bottlenecks mean EU clinicians and patients could lose access to medical devices under new rules

European clinicians and their patients could lose access to vital medical devices, including in-vitro diagnostics, due to a lack of agencies able to certify products in time to comply with strict new regulations.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement